XML 33 R12.htm IDEA: XBRL DOCUMENT v3.25.3
GOODWILL AND OTHER INTANGIBLE ASSETS
9 Months Ended
Sep. 30, 2025
GOODWILL AND OTHER INTANGIBLE ASSETS  
GOODWILL AND OTHER INTANGIBLE ASSETS

(6)   GOODWILL AND OTHER INTANGIBLE ASSETS

During the year ended December 31, 2021, the Company completed the acquisition of Kestrel Labs, which resulted in Goodwill of $20.4 million.

During the quarter ended September 30, 2025, the Company transitioned to an updated methodology for estimating the fair value of its reporting units for purposes of goodwill impairment testing. Previously, the Company used market capitalization as a proxy for reporting-unit fair value. The Company now estimates fair value at the reporting-unit level using discounted cash flows that incorporate the Company’s new managements’ business expectations. This refinement represents a change in accounting estimate under ASC 250-10 and was applied prospectively. The change affects goodwill impairment testing in the current and future periods.

During the quarter ended September 30, 2025 the Company recorded an impairment charge of $20.4 million on goodwill associated with ZMS (See Note 7 - Impairment).

The following table provides the summary of the Company’s intangible assets as of September 30, 2025.

Weighted-

 

Average

 

Gross

 

Remaining

 

Carrying

 

Accumulated

 

Net Carrying

 

Life (in

    

Amount

    

Amortization

    

Amount

    

years)

Acquired patents at December 31, 2024

$

10,000

$

(2,753)

$

7,247

8.00

Amortization expense

(679)

(679)

Impairment charges

(10,000)

3,432

(6,568)

Acquired patents at September 30, 2025

$

$

$